Pharmalucence builds radiopharma facility; Ghana anti-counterfeiting system connectivity a "go;"

> Radiopharmaceuticals maker Pharmalucence is replacing and modernizing its manufacturing infrastructure by building a 70,000 square foot production facility in Billerica, MA. Release

> The first phase is underway of an mPedigree system in Ghana, reported earlier, in which consumers text scratch codes via cell phone to verify drug authenticity: A test has demonstrated connectivity with the Hewlett-Packard data center. Article

> Third-party logistics provider DRS Group of Hyderabad has launched the DRS Labs contract manufacturing division by unveiling a 40,000-square-foot facility for the production of tablets, capsules, liquids and ointments. Article

> Virtify, maker of the Enterprise Content Compliance software, has been named to Gartner's list of "Cool Vendors in Life Sciences." Release

> KV Pharmaceutical has finally closed on the sale of its raw-material and drug-making subsidiary Particle Dynamics to an investor group, five years after a fire delayed the transaction. Article

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.